2025년 5월 신약개발관련 주요 Deal
주요 라이센싱 및 파트너십
No |
Date |
Investors/ Licensee |
Service Provider/ Licensor |
Assets |
MoA |
Indication |
Stage |
Value (USD Mn) |
|
1 |
5/6 |
Eli Lilly |
Alchemab Therapeutics |
ATLX-1282 |
αUNC5C mA9433b |
Neurology |
ALS |
Preclinical |
415 |
2 |
5/14 |
GSK |
Boston |
Efimosfermin alfa |
FGF21R modulator |
Metabolic Disorder |
MASH, Liver diseases |
Phase 2 |
1,200 |
3 |
5/14 |
AbbVie |
ADARx Pharmaceuticals |
n/d |
siRNA program |
Neurology, Immunology, Oncology |
n/d |
n/d |
335 |
4 |
5/14 |
Novo Nordisk |
Septerna |
n/d |
GPCR targeting program |
Metabolic Disorder |
Obesity, T2D, Cardio-metabolic diseases |
n/d |
2,200 |
5 |
5/15 |
Eli Lilly |
Rznomics |
n/d |
RNA-editing therapies using trans-splicing ribozyme platform |
Others |
Hearing loss |
n/d |
1,300 |
6 |
5/19 |
CRISPR Therapeutics |
Sirius Therapeutics |
SRSD107 |
FXI siRNA |
Cardiovascular Disease |
Thrombosis |
Phase 1 |
n/d |
7 |
5/19 |
Pfizer |
3S Bio |
SSGJ-707 |
VEGF x PD-1 BsAbs |
Oncology |
NSCLC, Colorectal Cancer, Endometrial Cancer, Ovarian Cancer |
Phase 2 |
6,050 |
8 |
5/21 |
Genentech |
Orionis Biosciences |
Allo-GlueTM |
Small-molecule monovalent glue |
n/d |
n/d |
n/d |
2,105 |
9 |
5/26 |
Servier |
BioNova Pharmaceuticals |
BN104 |
Menin inhibitor |
Oncology |
Acute
myeloid leukemia, |
Phase 1/2 |
n/d |
10 |
5/27 |
Biogen |
City Therapeutics |
n/d |
RNAi engineering tech |
Neurology |
CNS diseases |
n/d |
1,000 |
11 |
5/29 |
Astellas Pharma |
Evopoint Biosciences |
XNW27011 |
CLDN18.2 ADC |
Oncology |
Solid tumors; GI cancers |
Phase 1/2 |
1,340 |
(n/d=non-disclosure)
주요 M&A
No |
Date |
Acquires |
Issuer |
Assets |
MoA |
Indications |
Status |
Value (USD Mn) |
|
1 |
5/16 |
BioMarin |
Inozyme |
INZ-701 |
ENPP1 gene modulator |
Others |
ENPP1 deficiency |
Phase 3 |
270 |
2 |
5/19 |
Sanofi |
Vigil Neuroscience |
VG-3927 |
TREM2 agonist |
Neurology |
Alzheimer’s diseases |
Phase 1 |
256 |
3 |
5/27 |
Eli Lilly |
SiteOne Therapeutics |
STC-004 |
Nav1.8 inhibitor |
Neurology |
Pain |
Phase 2 |
1,000 |
Reference
각 사 홈페이지 / Cortellis / BioCentury / Globaldata / Fierce
Biotech
이전
2025.05.15
다음